Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Registry to Evaluate the Safety and Efficacy of the The SUPRAFLEX CRUZ™ Sirolimus Eluting Coronary Stent System in the Treatment of an Octo- and Nonagenerian All-Comer Patient Cohort With Coronary Artery Disease - the Cruz Senior Study

NCT04612179 is registered in ClinicalTrials.gov with IHF GmbH - Institut für Herzinfarktforschung as lead sponsor.

NCT NCT04612179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04612179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Registry to Evaluate the Safety and Efficacy of the The SUPRAFLEX CRUZ™ Sirolimus Eluting Coronary Stent System in the Treatment of an Octo- and Nonagenerian All-Comer Patient Cohort With Coronary Artery Disease - the Cruz Senior Study
Lead sponsor
IHF GmbH - Institut für Herzinfarktforschung
Phase
Observational
Overall status
Completed
Start date
June 23, 2021
Completion date
June 12, 2025
Enrollment
2,017 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary disease